Table 1.
Characteristics | No. of patients |
---|---|
Age (years) | |
Median | 63 |
Range | 47–72 |
Gender | |
Male | 42 |
Female | 31 |
ECOG score | |
0 | 40 |
1 | 29 |
2 | 4 |
Primary tumor | |
Colon | 60 |
Rectum | 13 |
Metastasis site | |
Liver | 41 |
Lung | 28 |
Local abdominal mass | 10 |
Peritoneum | 10 |
No. of metastatic sites | |
1 | 59 |
>1 | 14 |
Chemotherapy regimen | |
Cetuximab+FOLFOX | 41 |
Cetuximab+FOLFIRI | 32 |
Elevated markers at baseline | |
CEA (>5 ng/ml) | 65 |
CA19-9 (>37 U/ml) | 59 |